These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19224914)

  • 1. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.
    Wang J; Rajput A; Kan JL; Rose R; Liu XQ; Kuropatwinski K; Hauser J; Beko A; Dominquez I; Sharratt EA; Brattain L; Levea C; Sun FL; Keane DM; Gibson NW; Brattain MG
    J Biol Chem; 2009 Apr; 284(16):10912-22. PubMed ID: 19224914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
    Thangasamy A; Rogge J; Ammanamanchi S
    J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
    Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
    Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
    Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells.
    Park JS; Khoi PN; Joo YE; Lee YH; Lang SA; Stoeltzing O; Jung YD
    Int J Oncol; 2013 Mar; 42(3):1120-6. PubMed ID: 23337910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells.
    Chung CY; Park YL; Song YA; Myung E; Kim KY; Lee GH; Ki HS; Park KJ; Cho SB; Lee WS; Jung YD; Kim KK; Joo YE
    Dig Dis Sci; 2012 Feb; 57(2):371-80. PubMed ID: 21901254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma.
    Kim SA; Yoon TM; Lee DH; Park YL; Lee KH; Lim SC; Joo YE; Lee JK
    Auris Nasus Larynx; 2014 Apr; 41(2):201-6. PubMed ID: 24287326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cells.
    Park JS; Park JH; Lee S; Joo YE; Jung YD
    Oncol Rep; 2010 Sep; 24(3):709-14. PubMed ID: 20664977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.
    Ling Y; Kuang Y; Chen LL; Lao WF; Zhu YR; Wang LQ; Wang D
    Oncotarget; 2017 Jun; 8(24):39101-39116. PubMed ID: 28388571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model.
    Guo XN; Rajput A; Rose R; Hauser J; Beko A; Kuropatwinski K; LeVea C; Hoffman RM; Brattain MG; Wang J
    Cancer Res; 2007 Jun; 67(12):5851-8. PubMed ID: 17575153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
    Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
    Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.
    Yoon TM; Kim SA; Park YL; Lee KH; Sung MW; Lee JK; Lim SC; Chung IJ; Joo YE
    Head Neck; 2013 Aug; 35(8):1106-13. PubMed ID: 22887469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.
    Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE
    Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
    Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
    Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway.
    Li Q; Li M; Wang YL; Fauzee NJ; Yang Y; Pan J; Yang L; Lazar A
    Cell Physiol Biochem; 2012; 29(3-4):361-72. PubMed ID: 22508044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.
    Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH
    Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.
    Bieniasz M; Radhakrishnan P; Faham N; De La O JP; Welm AL
    Clin Cancer Res; 2015 Dec; 21(24):5588-600. PubMed ID: 26289070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.
    Narasimhan M; Ammanamanchi S
    Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.